Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


12.02.2024

2 AJR Am J Roentgenol
1 Am J Clin Oncol
1 Ann Oncol
5 Ann Surg Oncol
1 Ann Thorac Surg
3 Anticancer Res
4 Arch Bronconeumol
6 BMC Cancer
1 Br J Cancer
2 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
1 Cancer Res
1 Cancer Sci
2 Clin Lung Cancer
1 Clin Nucl Med
3 Eur J Cancer
2 Eur J Cardiothorac Surg
3 J Cancer Res Clin Oncol
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Thorac Cardiovasc Surg
11 J Thorac Oncol
3 Lancet Oncol
6 Lung Cancer
2 N Engl J Med
2 PLoS One
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. USUZAKI T
    Editorial Comment: Implementing an End-to-End Deep Learning Model in the Task of Differentiating Pure Ground-Glass Nodules on Chest CT.
    AJR Am J Roentgenol. 2023 Aug 2. doi: 10.2214/AJR.23.30002.
    PubMed        

  2. QI K, Wang K, Wang X, Zhang Y, et al
    Lung-PNet: An Automated Deep Learning Model for the Diagnosis of Invasive Adenocarcinoma in Pure Ground-Glass Nodules on Chest CT.
    AJR Am J Roentgenol. 2023 Jul 26. doi: 10.2214/AJR.23.29674.
    PubMed         Abstract available


    Am J Clin Oncol

  3. CANTRELL JN, Acharya P, Vesely SK, Gunter TC, et al
    Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score-matched NCDB Analysis.
    Am J Clin Oncol. 2023;46:503-511.
    PubMed         Abstract available


    Ann Oncol

  4. ROLFO C, Russo A
    Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer.
    Ann Oncol. 2024;35:147-149.
    PubMed        


    Ann Surg Oncol

  5. LIN JP, Chen XF, Wang P, He H, et al
    Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study.
    Ann Surg Oncol. 2024 Feb 9. doi: 10.1245/s10434-024-14983.
    PubMed         Abstract available

  6. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
    ASO Visual Abstract: CT-Based Deep Learning Model for Spread Through Air Spaces Prediction in Ground-Glass Predominant Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:1597-1598.
    PubMed        

  7. YOON DW, Hwang S, Hong TH, Choi YL, et al
    ASO Visual Abstract: Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
    Ann Surg Oncol. 2024;31:1591-1592.
    PubMed        

  8. PAN H, Huang J, Luo Q
    ASO Author Reflections: Should We Prefer Robotic over Thoracoscopic Surgery for Sublobar Resection in Octogenarians with Pulmonary Nodules
    Ann Surg Oncol. 2024;31:1585-1586.
    PubMed        

  9. LIN MW, Chen LW, Yang SM, Hsieh MS, et al
    CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground Glass-Predominant Lung Adenocarcinoma.
    Ann Surg Oncol. 2024;31:1536-1545.
    PubMed         Abstract available


    Ann Thorac Surg

  10. DUNNE EG, Fick CN, Isbell JM, Chaft JE, et al
    The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Feb 3:S0003-4975(24)00080.
    PubMed         Abstract available


    Anticancer Res

  11. MATSUMOTO T, Toya R, Shimohigashi Y, Yamaguchi K, et al
    Influence of Respiratory Motion on Dose Distribution in Gastric Mucosa-associated Lymphoid Tissue Lymphoma Radiotherapy.
    Anticancer Res. 2024;44:687-694.
    PubMed         Abstract available

  12. BARUT Z, Akdeniz FT, Isbir T
    Investigation of Mirna-223-3p Expression in Non-small Cell Lung Cancers.
    Anticancer Res. 2024;44:585-591.
    PubMed         Abstract available

  13. HONG JM, Jeong BK, Han D, Kim K, et al
    CCR10-mediated Enhancement of T Cell Trafficking for Improved Tumor Immunotherapy.
    Anticancer Res. 2024;44:521-532.
    PubMed         Abstract available


    Arch Bronconeumol

  14. MATOS I, do Bom-Sucesso M, Pinto D
    Large Inflammatory Myofibroblastic Tumor of the Lung in a Pediatric Patient.
    Arch Bronconeumol. 2024;60:103-104.
    PubMed        

  15. GARCIA-PRIETO F, Rodriguez Perojo A, Rio Ramirez MT
    Endobronchial Ultrasound: Detection of Lung Adenocarcinoma and Unmasking of Superior Vena Cava Thrombosis. An Exceptional Case.
    Arch Bronconeumol. 2024;60:113.
    PubMed        

  16. GARCIA PULIDO B, Fernandez Fernandez A
    Pulmonary Malt Lymphoma With Amyloidosis: An Uncommon Pulmonary Entity.
    Arch Bronconeumol. 2024;60:107-108.
    PubMed        

  17. ANDRES BLANCO AM, Terranova Rios M, Perez Rodriguez A
    Carcinosarcoma: A Rare Lung Tumor.
    Arch Bronconeumol. 2024;60:109.
    PubMed        


    BMC Cancer

  18. WANG Y, Ren H
    Multi-omics sequencing revealed endostar combined with cisplatin treated non small cell lung cancer via anti-angiogenesis.
    BMC Cancer. 2024;24:187.
    PubMed         Abstract available

  19. ZHAO M, Shao T, Shao H, Zhou C, et al
    Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis.
    BMC Cancer. 2024;24:186.
    PubMed         Abstract available

  20. ELSHAMI M, Sawafta N, Mansour A, Alser M, et al
    Anticipated time to seek medical advice for possible lung cancer symptoms and barriers to timely presentation in Palestine: a national cross-sectional study.
    BMC Cancer. 2024;24:183.
    PubMed         Abstract available

  21. YAN N, Zhang H, Shen S, Guo S, et al
    Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data.
    BMC Cancer. 2024;24:178.
    PubMed         Abstract available

  22. PHAM CP, Nguyen TTH, Do AT, Nguyen TK, et al
    A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam.
    BMC Cancer. 2024;24:176.
    PubMed         Abstract available

  23. WU J, Zhou Y, Xu C, Yang C, et al
    Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer.
    BMC Cancer. 2024;24:170.
    PubMed         Abstract available


    Br J Cancer

  24. FONT A, Mellado B, Climent MA, Virizuela JA, et al
    Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
    Br J Cancer. 2024;130:434-441.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  25. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    PubMed         Abstract available

  26. PELLAND-ST-PIERRE L, Pham MC, Nguyen AQH, Pasquet R, et al
    The Influence of Smoking and Occupational Risk Factors on DNA Methylation in the AHRR and F2RL3 Genes.
    Cancer Epidemiol Biomarkers Prev. 2024;33:224-233.
    PubMed         Abstract available


    Cancer Lett

  27. BISWAS U, Roy R, Ghosh S, Chakrabarti G, et al
    The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics.
    Cancer Lett. 2024 Feb 1:216662. doi: 10.1016/j.canlet.2024.216662.
    PubMed         Abstract available

  28. LIU X, Zheng W, Zhang L, Cao Z, et al
    Arginine methylation-dependent cGAS stability promotes non-small cell lung cancer cell proliferation.
    Cancer Lett. 2024 Feb 6:216707. doi: 10.1016/j.canlet.2024.216707.
    PubMed         Abstract available


    Cancer Res

  29. RIGAMONTI A, Viatore M, Polidori R, Rahal D, et al
    Integrating AI-powered digital pathology and imaging mass cytometry identifies key classifiers of tumor cells, stroma, and immune cells in non-small cell lung cancer.
    Cancer Res. 2024 Feb 5. doi: 10.1158/0008-5472.CAN-23-1698.
    PubMed         Abstract available


    Cancer Sci

  30. KAWAI S, Lin Y, Tsuge H, Ito H, et al
    Body mass index and lung cancer risk: Pooled analysis of 10 prospective cohort studies in Japan.
    Cancer Sci. 2024 Feb 4. doi: 10.1111/cas.16093.
    PubMed         Abstract available


    Clin Lung Cancer

  31. RODRIGUEZ-ABREU D, Bosch-Barrera J, Gray JE, Ahn MJ, et al
    STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.
    Clin Lung Cancer. 2024 Jan 6:S1525-7304(23)00267.
    PubMed         Abstract available

  32. DETTERBECK F, Ely S, Udelsman B, Blasberg J, et al
    So Now We Know-Reflections on the Extent of Resection for Stage I Lung Cancer.
    Clin Lung Cancer. 2023 Dec 28:S1525-7304(23)00262.
    PubMed         Abstract available


    Clin Nucl Med

  33. FAYAND A, Kerrou K, Wendum D, Grateau G, et al
    Malignant Peritoneal Mesothelioma Complicating Familial Mediterranean Fever on 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005041.
    PubMed         Abstract available


    Eur J Cancer

  34. STEMMER A, Margalit O, Serpas V, Strauss G, et al
    Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers.
    Eur J Cancer. 2023;198:113495.
    PubMed         Abstract available

  35. CHIANG Y, Lu LF, Tsai CL, Tsai YC, et al
    C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophages to facilitate metastatic potential after radiation.
    Eur J Cancer. 2024;198:113521.
    PubMed         Abstract available

  36. MARK M, Froesch P, Gysel K, Rothschild SI, et al
    First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17.
    Eur J Cancer. 2024;200:113600.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  37. MATSUI T, Takahashi Y, Nakada T, Sugita Y, et al
    Impact of intrapulmonary tumor location of non-small cell lung cancer on surgical outcomes for segmentectomy.
    Eur J Cardiothorac Surg. 2024 Feb 3:ezae036. doi: 10.1093.
    PubMed         Abstract available

  38. BRUNELLI A, Decaluwe H, Gonzalez M, Gossot D, et al
    Which extent of surgical resection thoracic surgeons would choose if they were diagnosed with an early-stage lung cancer: a European survey.
    Eur J Cardiothorac Surg. 2024;65:ezae015.
    PubMed        


    J Cancer Res Clin Oncol

  39. FAN X, Zhang Q, Qin S, Ju S, et al
    CircBRIP1: a plasma diagnostic marker for non-small-cell lung cancer.
    J Cancer Res Clin Oncol. 2024;150:83.
    PubMed         Abstract available

  40. DU C, Tan L, Xiao X, Xin B, et al
    Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancer.
    J Cancer Res Clin Oncol. 2024;150:77.
    PubMed         Abstract available

  41. CHENG X, Zhou J, Chen Y, Zhao Y, et al
    Patterns and trends of mortality from metastatic colorectal cancer in Shanghai, China from 2005 to 2021: a population-based retrospective analysis.
    J Cancer Res Clin Oncol. 2024;150:68.
    PubMed         Abstract available


    J Clin Oncol

  42. REMON J, Besse B, Aix SP, Callejo A, et al
    Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2024 Feb 7:JCO2301521. doi: 10.1200/JCO.23.01521.
    PubMed         Abstract available


    J Natl Cancer Inst

  43. MEERNIK C, Raveendran Y, Kolarova M, Rahman F, et al
    Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review.
    J Natl Cancer Inst. 2024 Feb 6:djae026. doi: 10.1093.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  44. CALL S, Reig-Oussedik N, Obiols C, Sanz-Santos J, et al
    Video-assisted mediastinoscopic lymphadenectomy (VAMLA): mature results for staging non-small cell lung cancer with normal mediastinum.
    J Thorac Cardiovasc Surg. 2024 Feb 2:S0022-5223(24)00098.
    PubMed         Abstract available


    J Thorac Oncol

  45. DACIC S, Cao X, Bota-Rabassedas N, Sanchez-Espiridion B, et al
    Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
    J Thorac Oncol. 2024;19:273-284.
    PubMed         Abstract available

  46. REMON J, Saw SPL, Cortiula F, Singh PK, et al
    Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges.
    J Thorac Oncol. 2024;19:199-215.
    PubMed         Abstract available

  47. VOKES EE, Mornex F, Sezer A, Cheng Y, et al
    Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study.
    J Thorac Oncol. 2024;19:285-296.
    PubMed         Abstract available

  48. ZHOU RX, Liao HJ, Hu JJ, Xiong H, et al
    Global burden of lung cancer attributable to household fine particulate matter pollution in 204 countries and territories, 1990-2019.
    J Thorac Oncol. 2024 Feb 2:S1556-0864(24)00034.
    PubMed         Abstract available

  49. FONG KM, Rosenthal A, Giroux DJ, Nishimura KK, et al
    The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming 9th edition of the TNM Classification of Lung Cancer.
    J Thorac Oncol. 2024 Feb 4:S1556-0864(24)00060.
    PubMed         Abstract available

  50. BERMAS BL, Gerber DE
    The Joint Problem of Rheumatoid Arthritis and Lung Cancer.
    J Thorac Oncol. 2024;19:196-198.
    PubMed        

  51. YUAN C, Huang R, Wang Y
    An Error in Modeling and the Selection of Independent Radiomics Variables Need Caution.
    J Thorac Oncol. 2024;19:344-345.
    PubMed        

  52. CHANG HC, Gau SY
    Real-World Evidence of the Association Between Rheumatoid Arthritis and Lung Cancer.
    J Thorac Oncol. 2024;19:346.
    PubMed        

  53. HORITA N, Takase-Minegishi K
    Information Bias Might Exaggerate Lung Cancer Risk of Patients With Rheumatoid Arthritis.
    J Thorac Oncol. 2024;19:348.
    PubMed        

  54. NISHIMURA T
    A Paradigm Shift in First-Line Treatment Can Have Many Implications For Second-Line Treatment.
    J Thorac Oncol. 2024;19:350.
    PubMed        

  55. TORASAWA M, Horinouchi H
    A Response to the Letter to the Editor: "A Paradigm Shift in First-Line Treatment Can Have Many Implications for Second-Line Treatment".
    J Thorac Oncol. 2024;19:351-352.
    PubMed        


    Lancet Oncol

  56. HUANG CY, Wu XB
    Pembrolizumab plus chemotherapy for advanced gastric cancer.
    Lancet Oncol. 2024;25:e50.
    PubMed        

  57. SCHUTTE T, Derks S, van Laarhoven HWM
    Pembrolizumab plus chemotherapy for advanced gastric cancer.
    Lancet Oncol. 2024;25:e51.
    PubMed        

  58. RHA SY, Bordia S
    Pembrolizumab plus chemotherapy for advanced gastric cancer - Authors' reply.
    Lancet Oncol. 2024;25:e52.
    PubMed        


    Lung Cancer

  59. BURNS L, Tukachinsky H, Raskina K, Huang RSP, et al
    Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
    Lung Cancer. 2024;188:107454.
    PubMed         Abstract available

  60. KITAGAWA S, Zenke Y, Taki T, Aokage K, et al
    Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
    Lung Cancer. 2024;188:107453.
    PubMed         Abstract available

  61. ZHANG YH, Liu XS, Gao Y, Yuan LL, et al
    SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with (18)F-FDG metabolic parameters.
    Lung Cancer. 2024;188:107449.
    PubMed         Abstract available

  62. LIU SV, Frohn C, Minasi L, Fernamberg K, et al
    Real-world outcomes associated with afatinib use in patients with solid tumors harboring NRG1 gene fusions.
    Lung Cancer. 2024;188:107469.
    PubMed         Abstract available

  63. HUANG S, Zhao M, Li S, Chen T, et al
    Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma.
    Lung Cancer. 2024;189:107472.
    PubMed         Abstract available

  64. KUNIMASA K, Tamiya M, Inoue T, Kawamura T, et al
    Clinical application of the Lung Cancer Compact Panel(TM) using various types of cytological specimens in patients with lung cancer.
    Lung Cancer. 2024;189:107498.
    PubMed         Abstract available


    N Engl J Med

  65. ZHOU C, Agrawal T, Girard N
    VTE with Amivantamab plus Chemotherapy in NSCLC. Reply.
    N Engl J Med. 2024;390:579-580.
    PubMed        

  66. MOIK F, Riedl JM, Ay C
    VTE with Amivantamab plus Chemotherapy in NSCLC.
    N Engl J Med. 2024;390:578-579.
    PubMed        


    PLoS One

  67. KANG J, Zhang J, Tian Z, Xu Y, et al
    The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis.
    PLoS One. 2024;19:e0276318.
    PubMed         Abstract available

  68. FAYA CASTILLO JE, Zapata Dongo RJ, Wong Chero PA, Infante Varillas SF, et al
    Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the treatment of non-small cell lung cancer.
    PLoS One. 2024;19:e0295966.
    PubMed         Abstract available


    Science

  69. BERNS A
    Transforming lung cancer types.
    Science. 2024;383:590-591.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.